These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20546271)

  • 1. Is bedtime supper necessary for older children with diabetes using glargine insulin in multiple daily injection regimens?
    Barton AL; Gilbertson HR; Donath SM; Cameron FJ
    Diabet Med; 2010 Feb; 27(2):238-41. PubMed ID: 20546271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes.
    Päivärinta M; Tapanainen P; Veijola R
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 2):83-90. PubMed ID: 18221431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
    Arutchelvam V; Heise T; Dellweg S; Elbroend B; Minns I; Home PD
    Diabet Med; 2009 Oct; 26(10):1027-32. PubMed ID: 19900235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG; Gebbie J; Home PD
    Diabet Med; 2006 Aug; 23(8):879-86. PubMed ID: 16911626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness of continuous glucose monitoring system (CGMS) in monitoring glycaemic profile in small children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Peczyńska J; Florys B; Kowalewski M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):237-43. PubMed ID: 16232362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Children and adolescents on intensive insulin therapy maintain postprandial glycaemic control without precise carbohydrate counting.
    Smart CE; Ross K; Edge JA; Collins CE; Colyvas K; King BR
    Diabet Med; 2009 Mar; 26(3):279-85. PubMed ID: 19317823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G; Laurenti O; Moretti A
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo-controlled trial.
    Dashora UK; Sibal L; Ashwell SG; Home PD
    Diabet Med; 2007 Apr; 24(4):344-9. PubMed ID: 17298589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive insulin treatment in diabetic children.
    Ludvigsson J; Bolli GB
    Diabetes Nutr Metab; 2001 Oct; 14(5):292-304. PubMed ID: 11806471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory 24-hour fast using flexible insulin therapy in patients with type 1 diabetes.
    Vigeral C; Sola-Gazagnes A; Nejjar S; M'Bemba J; Boitard C; Slama G; Elgrably F; Larger E
    Diabetes Metab; 2011 Dec; 37(6):553-9. PubMed ID: 21802332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of bedtime snack composition on prevention of nocturnal hypoglycemia in adults with type 1 diabetes undergoing intensive insulin management using lispro insulin before meals: a randomized, placebo-controlled, crossover trial.
    Kalergis M; Schiffrin A; Gougeon R; Jones PJ; Yale JF
    Diabetes Care; 2003 Jan; 26(1):9-15. PubMed ID: 12502652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus.
    Porter PA; Keating B; Byrne G; Jones TW
    J Pediatr; 1997 Mar; 130(3):366-72. PubMed ID: 9063410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are bedtime nutritional strategies effective in preventing nocturnal hypoglycaemia in patients with type 1 diabetes?
    Desjardins K; Brazeau AS; Strychar I; Rabasa-Lhoret R
    Diabetes Obes Metab; 2014 Jul; 16(7):577-87. PubMed ID: 24320159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exponential increase in postprandial blood-glucose exposure with increasing carbohydrate loads using a linear carbohydrate-to-insulin ratio.
    Marran KJ; Davey B; Lang A; Segal DG
    S Afr Med J; 2013 Apr; 103(7):461-3. PubMed ID: 23802208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes.
    Desjardins K; Brazeau AS; Strychar I; Leroux C; Gingras V; Rabasa-Lhoret R
    Diabetes Res Clin Pract; 2014 Dec; 106(3):420-7. PubMed ID: 25451901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [How to treat children and adolescents with type 1 diabetes mellitus?].
    Pulkkinen M; Laine T; Miettinen P
    Duodecim; 2011; 127(7):663-70. PubMed ID: 21553500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining uncertainty-aware predictive modeling and a bedtime Smart Snack intervention to prevent nocturnal hypoglycemia in people with type 1 diabetes on multiple daily injections.
    Mosquera-Lopez C; Roquemen-Echeverri V; Tyler NS; Patton SR; Clements MA; Martin CK; Riddell MC; Gal RL; Gillingham M; Wilson LM; Castle JR; Jacobs PG
    J Am Med Inform Assoc; 2023 Dec; 31(1):109-118. PubMed ID: 37812784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.